Integral Ad Science (NASDAQ:IAS) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Integral Ad Science (NASDAQ:IASGet Free Report) posted its earnings results on Friday. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.03), Zacks reports. The business had revenue of $153.00 million for the quarter, compared to analyst estimates of $148.83 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Integral Ad Science’s revenue was up 13.9% compared to the same quarter last year. During the same period last year, the business earned $0.06 EPS. Integral Ad Science updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

Integral Ad Science Trading Up 9.0 %

NASDAQ IAS opened at $10.52 on Friday. Integral Ad Science has a 52 week low of $7.98 and a 52 week high of $13.62. The firm has a 50 day moving average of $10.33 and a two-hundred day moving average of $10.82. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $1.71 billion, a PE ratio of 52.60, a price-to-earnings-growth ratio of 1.06 and a beta of 1.46.

Insider Activity

In other news, CEO Lisa Utzschneider sold 5,940 shares of the stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $9.75, for a total value of $57,915.00. Following the transaction, the chief executive officer now owns 266,926 shares in the company, valued at approximately $2,602,528.50. This represents a 2.18 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In the last three months, insiders have sold 19,109 shares of company stock worth $197,696. 2.00% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on IAS shares. Oppenheimer restated an “outperform” rating on shares of Integral Ad Science in a research report on Friday. Barclays restated an “equal weight” rating on shares of Integral Ad Science in a report on Friday. Piper Sandler cut their price target on shares of Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 13th. Scotiabank started coverage on shares of Integral Ad Science in a research note on Friday. They issued a “sector perform” rating for the company. Finally, Craig Hallum dropped their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Integral Ad Science presently has a consensus rating of “Moderate Buy” and an average target price of $14.67.

Read Our Latest Stock Analysis on Integral Ad Science

About Integral Ad Science

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Featured Articles

Earnings History for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.